Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
Month: September 2024
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s...
Avenue Therapeutics to Participate in Upcoming Investor Conferences
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
CVRx Announces Appointment of Two New Board Members
Kevin Ballinger and Mitch Hill appointed as new independent Board membersMINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:...
Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet...
Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
NORCROSS, Ga., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...
Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader...
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with...
Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)
10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort...
Better Choice Company Signs Definitive Agreement to Acquire SRx Health for Approximately $125 Million
Combined company will emerge as a leading global health and wellness company by providing products and solutions for families to...
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories
NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of LivesMALVERN, Pa., Sept. 03, 2024 (GLOBE...
Tinley’s Announces the Closing of its Non-Brokered Private Placement and Debt Settlement with an Aggregate Transaction Value of Approximately $8.3 Million
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - September 3, 2024) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB:...
PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...
MedsEngine Presents at ESC in London, U.K.
DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC is a clinical decision support company that develops software for treating chronic disease. Data was presented...
MedsEngine Presents at ESC in London, U.K.
DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC is a clinical decision support company that develops software for treating chronic disease. Data was presented...
Choose Your Motion with restor3d: Introducing the Latest Personalized Solution in the Kinos Total Ankle System, Kinos Range
DURHAM, N.C.--(BUSINESS WIRE)--#ChooseYourMotion--restor3d, the medical technology leader in 3D printed, personalized orthopedic implants across the entire human body, announced the...
QingSong Health Chairman Speaks at Global Ethics Forum in Geneva: Advancing Ethical Leadership in Healthcare
GENEVA, Sept. 3, 2024 /PRNewswire/ -- At the Global Ethics Forum, a leading platform that convenes stakeholders from various sectors...
QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024
– Abstract on data from a two-part phase 1c, multiple ascending dose study accepted for oral presentation – – New...
Aidoc Launches Seven New AI Solutions to Tackle Europe’s Healthcare Challenges
Aidoc's new CE-marked AI solutions make its offering one of the most comprehensive in the field, enabling rapid delivery of...
iZafe Group Introduces a Groundbreaking Tripartite Collaboration Aimed at Enhancing Independence and Safety in Medical Care
STOCKHOLM, SWEDEN / ACCESSWIRE / September 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") today announces a...